Bezdech senny centralny
Zapobieganie i profilaktyka

Bezdech senny centralny (BSC) jest zaburzeniem oddychania podczas snu, wynikającym z dysfunkcji ośrodka oddechowego, różniącym się od obturacyjnego bezdechu sennego. Profilaktyka BSC opiera się na identyfikacji i leczeniu chorób współistniejących, takich jak niewydolność serca, choroby neurologiczne czy schorzenia nerek w stadium końcowym. Optymalizacja terapii kardiologicznej, kontrola chorób neurologicznych i nerek, a także modyfikacja farmakoterapii (redukcja opioidów, ograniczenie leków nasennych i sedatywnych) stanowią kluczowe elementy zapobiegania. Wskazane jest także wprowadzenie zmian stylu życia, takich jak utrzymanie prawidłowej masy ciała, regularna aktywność fizyczna, rzucenie palenia oraz zmiana pozycji snu, co może zmniejszyć częstość epizodów bezdechu.

Profilaktyka i zapobieganie w bezdechu sennym centralnym

Bezdech senny centralny (BSC) to zaburzenie oddychania podczas snu charakteryzujące się okresami przerw w oddychaniu wynikającymi z braku lub zmniejszonego wysiłku oddechowego. W przeciwieństwie do obturacyjnego bezdechu sennego, BSC ma związek z nieprawidłową funkcją ośrodka oddechowego w mózgu. Profilaktyka i zapobieganie tej chorobie koncentruje się na minimalizacji czynników ryzyka oraz wczesnym wykrywaniu i leczeniu chorób podstawowych.12

Leczenie chorób współistniejących

Podstawową strategią zapobiegania bezdechu sennego centralnego jest identyfikacja i leczenie chorób współistniejących, które mogą być jego przyczyną. BSC często występuje jako powikłanie innych schorzeń, a ich skuteczne leczenie może znacząco zmniejszyć nasilenie lub całkowicie wyeliminować epizody bezdechu centralnego.34

  • Optymalizacja leczenia niewydolności serca – BSC często towarzyszy niewydolności serca, a prawidłowe leczenie kardiologiczne może zmniejszyć częstość występowania epizodów bezdechu45
  • Leczenie chorób neurologicznych – schorzenia ośrodkowego układu nerwowego mogą prowadzić do BSC, ich kontrola pomaga w zapobieganiu zaburzeniom oddychania6
  • Kontrola chorób nerek – w przypadku pacjentów z chorobą nerek w stadium końcowym istnieją specyficzne metody zapobiegania, takie jak stosowanie buforu wodorowęglanowego podczas dializy czy dializa nocna7

Modyfikacja leków wywołujących bezdech centralny

Niektóre leki mogą wpływać na kontrolę oddychania i przyczyniać się do rozwoju bezdechu sennego centralnego. Modyfikacja farmakoterapii stanowi ważny element profilaktyki.38

  • Redukcja lub odstawienie opioidów – leki opioidowe (np. morfina, kodeina) są znaną przyczyną BSC; w przypadku gdy są one czynnikiem wywołującym bezdech, lekarz może zalecić zmniejszenie dawki lub zastąpienie ich innymi lekami38
  • Ograniczenie stosowania leków nasennych i sedatywnychbenzodiazepiny i inne leki o działaniu uspokajającym mogą nasilać BSC9
  • Unikanie alkoholu przed snem – alkohol może hamować ośrodek oddechowy i nasilać epizody bezdechu centralnego10

Modyfikacje stylu życia

Zmiany stylu życia mogą istotnie zmniejszyć ryzyko wystąpienia bezdechu sennego centralnego oraz poprawić ogólny stan zdrowia pacjenta.1112

  • Utrzymanie prawidłowej masy ciała – otyłość jest czynnikiem ryzyka bezdechu sennego, a redukcja masy ciała może zmniejszyć nasilenie objawów1311
  • Regularna aktywność fizyczna – ćwiczenia fizyczne poprawiają kondycję układu oddechowego i krążeniowego, co może zapobiegać BSC11
  • Rzucenie palenia – nikotyna wpływa na mięśnie utrzymujące drożność dróg oddechowych, zaprzestanie palenia może zmniejszyć ryzyko BSC9
  • Zmiana pozycji snu – pozycja na boku może zmniejszyć częstość epizodów bezdechu u niektórych pacjentów10

Wczesna diagnostyka i monitorowanie

Wczesne wykrycie i monitorowanie bezdechu sennego centralnego pozwala na szybkie wdrożenie odpowiedniego leczenia i zapobieganie powikłaniom.114

  • Regularne badania kontrolne u osób z grupy wysokiego ryzyka (pacjenci z niewydolnością serca, chorobami neurologicznymi)13
  • Badania snu (polisomnografia) u pacjentów z objawami sugerującymi bezdech senny2
  • Monitorowanie skuteczności terapii – po wdrożeniu leczenia regularne kontrole mogą pomóc w dostosowaniu terapii i zapobiec nawrotowi BSC15

Interwencje terapeutyczne stosowane w profilaktyce

Oprócz leczenia przyczynowego, w zapobieganiu następstwom bezdechu sennego centralnego stosuje się różne metody terapeutyczne, które mają na celu normalizację wzorca oddychania podczas snu.6

Terapia dodatnim ciśnieniem w drogach oddechowych

Urządzenia dostarczające dodatnie ciśnienie do dróg oddechowych stanowią podstawę leczenia bezdechu sennego centralnego i pomagają zapobiegać następstwom tej choroby.316

  • CPAP (Continuous Positive Airway Pressure) – urządzenie dostarczające stałe dodatnie ciśnienie w drogach oddechowych, zapobiegające ich zapadaniu się. CPAP jest uznawany za terapię pierwszego rzutu w BSC i może pomóc około 50-60% pacjentów.1718
  • BPAP (Bilevel Positive Airway Pressure) – dostarcza różne poziomy ciśnienia podczas wdechu i wydechu, co może być bardziej komfortowe dla niektórych pacjentów. BPAP jest zalecany zwłaszcza w przypadku BSC związanego z hipowendylacją.619
  • ASV (Adaptive Servo-Ventilation) – zaawansowane urządzenie, które dostosowuje dostarczane ciśnienie oddech po oddechu, wyrównując wzorzec oddychania. ASV jest szczególnie skuteczne w BSC związanym z niewydolnością serca, chociaż należy pamiętać, że u pacjentów z niewydolnością serca i obniżoną frakcją wyrzutową (<45%) stosowanie ASV może być przeciwwskazane.162021

Terapia tlenem

Suplementacja tlenu jest skuteczną metodą zapobiegania epizodom bezdechu centralnego, szczególnie u pacjentów z BSC związanym z niewydolnością serca.2219

  • Tlenoterapia nocna pomaga ustabilizować poziom tlenu we krwi, zmniejszając potrzebę nadmiernego oddychania23
  • Wykazano, że stosowanie tlenu zmniejsza liczbę epizodów bezdechu u pacjentów z przewlekłą niewydolnością serca24
  • Różne urządzenia dostarczające tlen mogą być dostosowane do indywidualnych potrzeb pacjenta25

Stymulacja nerwu przeponowego

Nowatorską metodą terapeutyczną w zapobieganiu BSC jest implantowana stymulacja nerwu przeponowego, która przywraca prawidłowy wzorzec oddychania podczas snu.2024

  • System remedē – urządzenie zatwierdzone przez FDA, implantowane pod skórą w górnej części klatki piersiowej, które dostarcza impuls elektryczny do nerwu przeponowego podczas snu, powodując wdech2221
  • Stymulacja nerwu przeponowego jest wskazana w umiarkowanym do ciężkiego BSC u dorosłych pacjentów26
  • Może być stosowana u pacjentów, u których inne terapie (CPAP, ASV, tlenoterapia) nie przyniosły odpowiednich rezultatów27
  • Wykazano, że zmniejsza nasilenie BSC, poprawia jakość snu oraz jakość życia, nawet u pacjentów z niewydolnością serca2824

Farmakoterapia

Leki mogą być stosowane jako uzupełnienie innych metod profilaktycznych, szczególnie u pacjentów, którzy nie tolerują terapii dodatnim ciśnieniem.2218

  • Acetalozamid – lek moczopędny, który stymuluje oddychanie i może być stosowany w leczeniu pierwotnych zespołów bezdechu sennego centralnego1819
  • Teofilina – może być rozważana w leczeniu BSC związanego z niewydolnością serca po optymalizacji standardowej terapii medycznej19
  • Zolpidem i triazolam – mogą być rozważane w leczeniu pierwotnych zespołów BSC tylko jeśli pacjent nie ma czynników ryzyka depresji oddechowej18
  • Obecnie prowadzone są badania nad nowymi lekami (np. AD109), które mogą pomóc w leczeniu bezdechu sennego i zapobieganiu zamykaniu się górnych dróg oddechowych29

Multidyscyplinarne podejście do profilaktyki BSC

Kompleksowe zapobieganie bezdechu sennemu centralnemu wymaga współpracy specjalistów z różnych dziedzin medycyny.30

  • Kardiolodzy – optymalne leczenie niewydolności serca i zaburzeń rytmu serca może zmniejszyć nasilenie BSC31
  • Neurolodzy – diagnostyka i leczenie chorób neurologicznych, które mogą leżeć u podłoża BSC32
  • Pulmonolodzy – specjalistyczna ocena zaburzeń oddychania i dostosowanie odpowiednich terapii14
  • Specjaliści medycyny snu – monitorowanie i dostosowywanie leczenia30

Znaczenie wczesnej interwencji

Wczesne rozpoznanie i leczenie bezdechu sennego centralnego ma kluczowe znaczenie dla zapobiegania powikłaniom.132

  • Zapobieganie powikłaniom sercowo-naczyniowym – nieleczony BSC może prowadzić do zaostrzenia niewydolności serca, zaburzeń rytmu serca i nadciśnienia płucnego31
  • Poprawa jakości snu – wczesna interwencja może zapobiec fragmentacji snu i związanym z nią zaburzeniom poznawczym24
  • Zmniejszenie ryzyka śmiertelności – odpowiednie leczenie BSC może zmniejszyć ryzyko zgonu, szczególnie u pacjentów z chorobami serca33

Indywidualizacja profilaktyki

Podejście do profilaktyki bezdechu sennego centralnego powinno być dostosowane do indywidualnych potrzeb pacjenta, z uwzględnieniem przyczyny BSC, chorób współistniejących oraz preferencji pacjenta.344

  • Stratyfikacja ryzyka – identyfikacja pacjentów wysokiego ryzyka i wdrożenie bardziej intensywnych działań profilaktycznych12
  • Dostosowanie terapii do typu BSC (związanego z hiperwendylacją lub hipowendylacją)6
  • Regularne kontrole i dostosowywanie leczenia w zależności od odpowiedzi na terapię15

Warto podkreślić, że w przypadku pacjentów z BSC, u których występuje zarówno komponent centralny, jak i obturacyjny, konieczne może być leczenie obu tych zaburzeń jednocześnie. Jak zauważył Dr M. Safwan Badr: „Jeśli skorygujemy bezdech centralny, ale pozostawimy nienaruszony bezdech obturacyjny, nie pomogliśmy pacjentowi. U dwóch trzecich pacjentów, którzy mają oba typy bezdechu, prawdopodobnie konieczne będzie leczenie obu tych stanów.”17

Działania profilaktyczne w różnych grupach pacjentów

Strategie profilaktyczne mogą różnić się w zależności od przyczyny BSC i grupy pacjentów.34

Pacjenci z niewydolnością serca

  • Optymalizacja leczenia kardiologicznego – właściwe leczenie niewydolności serca może zmniejszyć nasilenie BSC3
  • CPAP jako terapia pierwszego rzutu w BSC związanym z niewydolnością serca18
  • Tlenoterapia nocna jest wskazana w leczeniu zespołów bezdechu sennego centralnego związanych z niewydolnością serca19
  • Stymulacja nerwu przeponowego może być rozważana u pacjentów, którzy nie reagują na terapie konwencjonalne33

Pacjenci z chorobą nerek

  • Możliwe opcje leczenia BSC związanego z chorobą nerek w stadium końcowym obejmują: CPAP, suplementację tlenu, stosowanie buforu wodorowęglanowego podczas dializy i dializę nocną19

Pacjenci leczeni opioidami

  • Redukcja dawki opioidów lub zmiana na leki o mniejszym wpływie na ośrodek oddechowy3
  • BPAP lub ASV mogą być bardziej skuteczne niż CPAP u pacjentów z BSC indukowanym opioidami35

Zapobieganie bezsennemu sennemu centralnemu wymaga kompleksowego podejścia, uwzględniającego zarówno leczenie chorób podstawowych, jak i stosowanie odpowiednich terapii dostosowanych do indywidualnych potrzeb pacjenta. Wczesna interwencja i multidyscyplinarne podejście mogą znacząco zmniejszyć ryzyko powikłań i poprawić jakość życia pacjentów z tym zaburzeniem.112

Kolejne rozdziały

Zapraszamy do dalszego czytania naszego leksykonu.

Wybierz kolejny rozdział z menu poniżej, aby otworzyć nową podstronę kompedium wiedzy i uzyskać szczegółowe informację o leku, substancji lub chorobie.

  1. 11.04.2026
  2. www.leksykon.com.pl

Materiały źródłowe

  • #1 Central sleep apnea: Diagnosis and treatment
    https://www.medicalnewstoday.com/articles/central-sleep-apnea
    It is important to receive treatment for central sleep apnea in order to reduce the risk of other conditions. The primary goal of treatment will be to treat the underlying cause of the sleep apnea. […] Finding and treating the underlying cause of sleep apnea is crucial in preventing these serious complications. The overall outlook will depend on treating the underlying cause and avoiding these complications. […] Getting prompt and early treatment for central sleep apnea may help reduce the risk of long-term complications. […] Properly treating the underlying cause of central sleep apnea can stop or greatly reduce the apnea itself in many cases.
  • #2 Preventing Central Sleep Apnea: Risk Factors and Prevention Strategies
    https://www.darwynhealth.com/lung-pulmonary-health/lung-and-airways-disorders/sleep-apnea/central-sleep-apnea/preventing-central-sleep-apnea-risk-factors-and-prevention-strategies/?lang=en
    Central sleep apnea is a sleep disorder characterized by pauses in breathing during sleep. This article explores the risk factors associated with central sleep apnea and provides prevention strategies to reduce the chances of developing this condition. By understanding the causes and taking proactive steps, individuals can improve their sleep quality and overall well-being. […] Identifying these risk factors is crucial for preventing central sleep apnea. By addressing modifiable risk factors, such as maintaining a healthy weight, managing heart conditions, and avoiding medications that can affect breathing, individuals can reduce their risk of developing central sleep apnea. Additionally, regular screenings and sleep studies can help identify the condition early on, allowing for prompt intervention and treatment.
  • #3 Central sleep apnea – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/central-sleep-apnea/diagnosis-treatment/drc-20352114
    To address central sleep apnea, a health care professional may recommend a positive airway pressure machine. Positive airway pressure devices used for central sleep apnea include continuous positive airway pressure (CPAP), bilevel positive airway pressure (BPAP) and adaptive servo-ventilation (ASV). These devices deliver pressurized air through a tight-sealing mask to help support breathing. […] Treatments for central sleep apnea might include: […] Addressing associated medical problems. Possible causes of central sleep apnea include other disorders. Treating those conditions might help your central sleep apnea. For example, therapy for heart failure might improve central sleep apnea. […] Reduction of opioid medicines. If opioid medicines are causing your central sleep apnea, your health care team might reduce your dose of those medicines over time.
  • #4 Central Sleep Apnea: a Brief Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6883649/
    Management strategy for central apnea aim to eliminate abnormal respiratory events, stabilize sleep and alleviate the underlying clinical condition. Positive pressure therapy (PAP) remains a standard therapy for central as well as obstructive apnea. Other treatment options include adaptive-servo ventilation (ASV), supplemental oxygen, phrenic nerve stimulation, and pharmacologic therapy. However, ASV is contraindicated in patients with central sleep apnea who had heart failure with reduced ejection fraction, owing to increased mortality in this population. […] There are several therapeutic options for central apnea. Randomized controlled studies are needed to ascertain the long-term effectiveness of individual, or combination, treatment modalities in different types of central apnea. […] Optimal treatment of concomitant clinical conditions is a critical first step, which may result in amelioration of the severity of central apnea. Positive pressure therapy could be delivered as continuous positive airway pressure (CPAP), bi-level pressure (B-PAP) or Adaptive servo ventilation (ASV). CPAP is the recommended treatment first line therapy for central apnea with about 50% response rate.
  • #5 Central Sleep Apnoea (CSA) | Sleep Health Foundation
    https://www.sleephealthfoundation.org.au/sleep-disorders/central-sleep-apnoea-csa
    In Central Sleep Apnoea (CSA) breathing stops and there is a pause before there is an effort to breathe again. […] There are several possible treatment options for CSA, with CPAP being just one of them. […] Positive airway pressure therapies can help many forms of CSA. CPAP: Continuous Positive Airway Pressure may work. Adaptive servo ventilation is useful for some types of central apnoea although always recommended to be trialed under the guidance of a sleep physician. […] Oxygen therapy at night may be beneficial. […] Where heart failure is a factor, treatment of this with medications is important.
  • #6 Phrenic Nerve Stimulation for Central Sleep Apnea | Providers | Blue Cross NC
    https://www.bluecrossnc.com/providers/policies-guidelines-codes/commercial/surgery/updates/phrenic-nerve-stimulation-for-central-sleep-apnea
    The use of phrenic nerve stimulation for central sleep apnea is considered investigational in all situations. […] The goal of treatment is to normalize sleep-related breathing patterns. […] Because most cases of CSA are secondary to an underlying condition, central nervous system pathology, or medication side effects, treatment of the underlying condition or removal of the medication may improve CSA. […] For patients with hyperventilation-related CSA, continuous positive airway pressure (CPAP) is considered first-line therapy. […] For patients with hypoventilation-related CSA, first-line therapy is bilevel positive airway pressure. […] Pharmacologic therapy with a respiratory stimulant may be recommended to patients with hyper- or hypoventilation CSA who do not benefit from positive airway pressure devices, though close monitoring is necessary due to the potential for adverse effects such as rapid heart rate, high blood pressure, and panic attacks. […] The use of phrenic nerve stimulation for central sleep apnea is considered investigational in all situations.
  • #7 Updated Guidelines from AASM for the Treatment of Central Sleep Apnea Syndromes | AAFP
    https://www.aafp.org/pubs/afp/issues/2012/1115/p968.html
    Bilevel positive airway pressure therapy in a spontaneous timed mode targeted to normalize the apnea-hypopnea index may be considered for the treatment of central sleep apnea related to CHF only if there is no response to adequate trials of CPAP, adaptive servo-ventilation, and oxygen therapies. (Option.) […] Adaptive servo-ventilation targeted to normalize the apnea-hypopnea index is indicated for the treatment of central sleep apnea syndromes related to CHF. (Standard.) […] Nocturnal oxygen therapy is indicated for the treatment of central sleep apnea syndromes related to CHF. (Standard.) […] Acetazolamide and theophylline have limited supporting evidence, but may be considered for the treatment of central sleep apnea syndromes related to CHF after optimization of standard medical therapy, if positive airway pressure is not tolerated and if accompanied by close clinical follow-up. (Option.) […] The following possible treatment options for central sleep apnea syndromes related to end-stage renal disease may be considered: CPAP, supplemental oxygen, bicarbonate buffer use during dialysis, and nocturnal dialysis. (Option.)
  • #8 Central Sleep Apnea: Its Causes and Treatment
    https://sleeplay.com/blogs/news/central-sleep-apnea-causes-and-treatment?srsltid=AfmBOoprKNR3A6_JFwBFREt_A6dU6N-dWtQxBM6ZOY8ldHabSo5r9JyL
    Currently, there is no proper cure for central sleep apnea. However, there are ways to reduce its effects and get a restful nights sleep. […] Prevention of Opioid Medications Opioid medicines, like morphine and codeine, are known to cause central sleep apnea. Now, if that is the leading cause of your sleep apnea, you can either consult your doctor and change your medication or reduce its dose. […] You can also get medications for sleep apnea treatment if you do not wish to take a PAP therapy. These medications can help regulate your breathing pattern and give you a peaceful sleep during the night. […] Phrenic nerve stimulation is a newly developed treatment to reduce the effects of central sleep apnea in adults.
  • #9 Sleep Apnea Information & Treatment
    https://www.columbiadoctors.org/health-library/condition/sleep-apnea/
    You can help prevent obstructive sleep apnea if you try the following ideas. […] Don’t use alcohol or certain medicines before bed. Medicines to avoid include sleeping pills, opioids, and sedatives. These can relax your throat muscles and slow your breathing. […] Have a healthy lifestyle. Eat sensibly, exercise, and stay at a healthy weight. […] Quit smoking. The nicotine in tobacco relaxes the muscles that keep the airways open. If you don’t smoke, those muscles are less likely to collapse at night and narrow the airways.
  • #10 Understanding Central Sleep Apnea & Treatment Options | Sleep Disorders
    https://www.sleephealthsolutionsohio.com/blog/central-sleep-apnea/
    Available treatment options will depend mostly on the cause of your CSA. In some cases, treating the underlying condition, or modifying medications, may also resolve the sleep apnea. There are also medications that can be prescribed to help manage the symptoms of CSA. […] Lifestyle changes recommended to manage obstructive sleep apnea can also be helpful for those with CSA. These include: Losing weight, Avoiding alcohol, sleeping pills, and opioids, Quit smoking, and Change sleeping positions. […] Continuous positive airway pressure (CPAP) therapy can help people with all types of sleep apnea. It works by pushing air into the respiratory tract through the mouth or nose via tubing and a mask. The pressurized air helps keep the airway open and stimulate regular breathing. PAP devices like CPAP and BPAP are also used in the management and treatment of central sleep apneas, helping to stabilize sleep and suppress abnormal respiratory events.
  • #11 Understanding Central Sleep Apnea & Treatment Options | Sleep Disorders
    https://www.sleephealthsolutionsohio.com/blog/central-sleep-apnea/
    Managing central sleep apnea (CSA) requires a comprehensive approach that combines lifestyle changes, medical treatments, and device therapies. Here are some effective strategies to manage CSA: Lifestyle Changes: Maintaining a healthy weight, engaging in regular exercise, and avoiding alcohol and sedatives can significantly alleviate CSA symptoms. These changes help improve overall respiratory health and reduce the frequency of apneas. […] Continuous Positive Airway Pressure (CPAP) Therapy: CPAP therapy is a common and effective treatment for CSA. It involves wearing a mask over the nose or mouth while sleeping, which delivers a constant flow of air pressure to keep the airways open and stimulate regular breathing. […] Certain medications, such as acetazolamide and theophylline, may be prescribed to stimulate breathing and improve respiratory drive. These medications can help manage the symptoms of CSA and improve sleep quality.
  • #12 Preventing Central Sleep Apnea: Risk Factors and Prevention Strategies
    https://www.darwynhealth.com/lung-pulmonary-health/lung-and-airways-disorders/sleep-apnea/central-sleep-apnea/preventing-central-sleep-apnea-risk-factors-and-prevention-strategies/?lang=en
    Prevention strategies for central sleep apnea primarily revolve around lifestyle modifications and medical interventions. By implementing these strategies, individuals can significantly reduce the risk of developing the condition and improve their overall sleep quality. […] By addressing these modifiable risk factors, individuals can take proactive steps towards preventing central sleep apnea and improving their overall sleep quality. […] To mitigate the risk of complications, it is crucial to seek medical evaluation and treatment for central sleep apnea. Effective management strategies, such as continuous positive airway pressure (CPAP) therapy, can help alleviate symptoms, improve sleep quality, and reduce the likelihood of developing complications associated with central sleep apnea.
  • #13
    https://healthmatch.io/central-sleep-apnea
    There is nothing you can do to totally eliminate your risk of central sleep apnea. However, its always a smart idea to live as healthy a lifestyle as possible by staying active, eating a healthy diet, and getting regular checkups from your doctors. […] Maintaining a healthy lifestyle as you age is the best thing you can do to help prevent the most serious medical conditions that may develop over time, including central sleep apnea. Talk to your doctor about how to reduce your risk for disease as you get older.
  • #14 Reddit – The heart of the internet
    https://www.reddit.com/r/SleepApnea/comments/14cqt6k/its_not_all_in_my_head_its_actually_severe/
    When I finally got a sleep test done, it quickly relieved severe central sleep apnea. […] Tomorrow is my appointment with my respirologist who will prescribe me my treatment and I’m beyond excited. […] If you think you may have sleep apnea don’t stop until you know for sure that you do or you don’t. Demand things from your doctor, they are there to work for you, so put them to work. You know your body best, and you deserve to live a better life than the one you probably live now. Don’t let undiagnosed untreated sleep apnea steal 10+ years of your life.
  • #15 Treating and Managing Sleep Apnea | American Lung Association
    https://www.lung.org/lung-health-diseases/lung-disease-lookup/sleep-apnea/treating-and-managing
    Many of the above treatment options may also be considered for central sleep apnea. Other treatments your healthcare provider may discuss with you include adjusting current medications that may affect your nighttime breathing, adding medication to stimulate breathing or surgical considerations such as a nerve stimulator. […] If you had surgery to treat sleep apnea, you may need a follow-up sleep study to make sure your sleep apnea has improved. You also may need to repeat a sleep study if you gain or lose weight. Over time, scar tissue or relaxation of your muscles can cause sleep apnea to return, so keep your healthcare provider informed about any sleep symptoms you experience.
  • #16 Central sleep apnea – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/central-sleep-apnea/diagnosis-treatment/drc-20352114
    Continuous positive airway pressure (CPAP). This method, also used to treat obstructive sleep apnea, involves wearing a mask over the nose or over the nose and mouth while asleep. […] The mask is attached to a small pump that supplies a continuous amount of pressurized air to hold open the upper airway. CPAP may prevent the airway closure that can trigger central sleep apnea. […] Adaptive servo-ventilation (ASV). If CPAP doesn’t effectively treat your condition, you might be given ASV. Like CPAP, ASV also delivers pressurized air. […] Unlike CPAP, ASV adjusts the amount of pressure breath-by-breath when you take a breath. This smooths out your breathing pattern. The device also might automatically deliver a breath if you haven’t taken a breath within a certain number of seconds. […] Bilevel positive airway pressure (BPAP). Like ASV, BPAP delivers a set amount pressure when you breathe in and a different amount of pressure when you breathe out.
  • #17 M. Safwan Badr, MD: What are the Novel Treatments for Central Sleep Apnea?
    https://www.hcplive.com/view/m-safwan-badr-md-what-are-the-novel-treatments-for-central-sleep-apnea-
    At SLEEP 2024, Badr presented on novel treatments for central sleep apnea like phrenic nerve stimulation. […] Effective traditional treatments exist for CSA, like positive airway pressure therapy, supplemental oxygen, and adaptive servo ventilation. Continuous positive airway pressure (CPAP) is a first line therapy and helps 50% to 60% of individuals with CSA. Novel treatments for CSA include phrenic nerve stimulation and pharmacological therapy. […] I would envision that many future interventions will involve CPAP plus another intervention because if you correct the central apnea but leave the obstructive apnea untouched, we haven’t helped you, Badr said. For the two thirds of the patients who have both, it will probably be treatment of both conditions.
  • #18 Updated Guidelines from AASM for the Treatment of Central Sleep Apnea Syndromes | AAFP
    https://www.aafp.org/pubs/afp/issues/2012/1115/p968.html
    Central sleep apnea syndromes are characterized by sleep-disordered breathing associated with absent or diminished respiratory effort. […] Positive airway pressure therapy may be considered for the treatment of primary central sleep apnea syndromes. (Option.) […] Acetazolamide has limited supporting evidence, but may be considered for the treatment of primary central sleep apnea syndromes. (Option.) […] The use of zolpidem (Ambien) and triazolam (Halcion) may be considered for the treatment of primary central sleep apnea syndromes only if the patient does not have underlying risk factors for respiratory depression. (Option.) […] CPAP therapy targeted to normalize the apnea-hypopnea index is indicated for the initial treatment of central sleep apnea syndromes related to congestive heart failure (CHF). (Standard.)
  • #19 Updated Guidelines from AASM for the Treatment of Central Sleep Apnea Syndromes | AAFP
    https://www.aafp.org/pubs/afp/issues/2012/1115/p968.html
    Bilevel positive airway pressure therapy in a spontaneous timed mode targeted to normalize the apnea-hypopnea index may be considered for the treatment of central sleep apnea related to CHF only if there is no response to adequate trials of CPAP, adaptive servo-ventilation, and oxygen therapies. (Option.) […] Adaptive servo-ventilation targeted to normalize the apnea-hypopnea index is indicated for the treatment of central sleep apnea syndromes related to CHF. (Standard.) […] Nocturnal oxygen therapy is indicated for the treatment of central sleep apnea syndromes related to CHF. (Standard.) […] Acetazolamide and theophylline have limited supporting evidence, but may be considered for the treatment of central sleep apnea syndromes related to CHF after optimization of standard medical therapy, if positive airway pressure is not tolerated and if accompanied by close clinical follow-up. (Option.) […] The following possible treatment options for central sleep apnea syndromes related to end-stage renal disease may be considered: CPAP, supplemental oxygen, bicarbonate buffer use during dialysis, and nocturnal dialysis. (Option.)
  • #20 Central Sleep Apnea: a Brief Review
    https://pmc.ncbi.nlm.nih.gov/articles/PMC6883649/
    The development of central apnea may be mitigated by altering the mode of delivering positive pressure therapy. Specifically, Adaptive Servo Ventilation (ASV) provides varying amount of ventilatory support, against a background of positive end expiratory pressure (EPAP). […] The role of pharmacological therapy for central apnea is very modest, and there are no long-term controlled clinical trials demarcating the boundaries of effectiveness. […] Several studies have demonstrated a salutary effect of supplemental O2 in patients with central apnea associated with heart failure. […] Stimulation of the phrenic nerve is a physiologically appealing intervention that may be an option for patients with central apnea. A new commercially available implantable phrenic nerve stimulator that provides unilateral stimulation of the phrenic nerve has been recently approved by the FDA for the treatment of moderate to severe central sleep apnea (CSA) in adult patients.
  • #21 Identification and Treatment of Central Sleep Apnoea: Beyond SERVE-HF | CFR Journal
    https://www.cfrjournal.com/articles/identification-and-treatment-central-sleep-apnoea-beyond-serve-hf?language_content_entity=en
    A recently approved therapy has taken a physiological approach to treatment, stimulating the phrenic nerve to restore a normal breathing pattern. This therapy has been demonstrated to improve CSA and QOL. […] Regardless of whether the pattern is CheyneStokes or non-CheyneStokes, the effects of the breathing disorder result in a number of devastating effects to the cardiovascular system. Intermittent hypoxia leads to inflammation, tissue ischaemia and endothelial dysfunction. […] A number of therapeutic approaches have been utilised for the treatment of CSA. […] Following the SERVE-HF Trial, most other research with ASV was stopped. However, the Effect of ASV on Survival and Hospital Admissions in HF (ADVENT-HF) study continues. […] The FDA recently approved a therapeutic approach to treat CSA by replacing the delayed signalling. Phrenic nerve stimulation uses neurostimulation to stimulate a single phrenic nerve at night, which restores a normal breathing pattern and stabilises carbon dioxide levels.
  • #22 Central sleep apnea – Diagnosis and treatment – Mayo Clinic
    https://www.mayoclinic.org/diseases-conditions/central-sleep-apnea/diagnosis-treatment/drc-20352114
    Supplemental oxygen. Using supplemental oxygen while you sleep might help if you have central sleep apnea. Various devices are available to deliver oxygen to your lungs. […] Medicines. Medicines such as acetazolamide have been used to stimulate breathing in people with central sleep apnea. These medicines might be prescribed to help your breathing as you sleep if you can’t tolerate positive airway pressure. […] A newer therapy for central sleep apnea is transvenous phrenic nerve stimulation. A device approved by the U.S. Food and Drug Administration known as Remede System delivers an electrical pulse to the nerve that controls the diaphragm during sleep. This causes you to take a breath. The system includes a battery-powered pulse generator that’s implanted under the skin in the upper chest. […] Used for moderate to severe central sleep apnea, this system produces a steady breathing pattern. More study is needed.
  • #23
    https://wesper.co/blogs/wesper-journal/treatment-options-for-central-sleep-apnea
    Supplemental oxygen has become an effective treatment for patients with central sleep apnea (CSA), particularly those experiencing Cheyne-Stokes breathing-central sleep apnea (CSB-CSA) due to heart failure. This therapy stabilizes the body’s oxygen levels during sleep, thereby reducing the need for excessive breathing. […] In conclusion, whether managing CSA due to heart failure or adapting to high-altitude environments, supplemental oxygen serves as an effective solution. It helps stabilize breathing patterns during sleep and optimizes overall sleep architecture, fostering a more restorative night vital for healing and health maintenance. […] The remed System is an implantable device that uses phrenic nerve stimulation to regulate breathing patterns during sleep. It is designed to be minimally invasive and offers improved comfort and compliance compared to traditional therapies, significantly reducing sleep apnea severity in patients.
  • #24 Central Sleep Apnea Treatments: PAP Machines, Oxygen Therapy, and More
    https://www.healthline.com/health/central-sleep-apnea-treatment
    Treatments for central sleep apnea may include a PAP machine, oxygen therapy, phrenic nerve stimulator, or medication. […] Treating central sleep apnea can help prevent the development of long-term health complications. […] The treatment goal for central sleep apnea is to reduce complications from insufficient sleep and lower the risk of related chronic conditions by minimizing the number of sleep disturbances you experience. […] PAP machines can help keep your airways open while you sleep, which stabilizes the amount of air coming in and out of your body. […] The use of oxygen has been shown to decrease the number of apneic episodes for those with chronic heart failure. […] Phrenic nerve stimulators have been shown to: reduce central sleep apnea severity, improve sleep quality, improve quality of life even in people with heart failure. […] Central sleep apnea may be treated with a PAP machine, oxygen, phrenic nerve stimulator, or medications.
  • #25 Treatment Options for Central Sleep Apnea | Trogolo Obstetrics and Gynecology
    https://www.toplinemd.com/trogolo-obstetrics-and-gynecology/treatment-options-for-central-sleep-apnea/
    One should never ignore central sleep apnea. This is a serious respiratory disorder that could lead to many other complications and a significant drop in the quality of life. […] As stated, a very common cause of sleep apnea can be found in other health conditions. In that sense, treating these conditions could end up treating the breathing issue as well. […] In case the main culprit of your central sleep apnea is the opioid drug you’re taking, chances are your doctor will reduce the dose of the said drug gradually. […] There are several different devices that can help with supplemental oxygen delivery to your lungs and airways while you sleep. Your doctor should determine the best one for you. […] Finally, if everything else fails, it’s possible to get surgery that will manage the symptoms of central sleep apnea. This is especially effective for people with heart conditions. The process involves the implementation of a nerve stimulator inside the patient’s chest that will then stimulate the brain-diaphragm nerve, thus regulating breathing during sleep.
  • #26 Innovative treatment for Central Sleep Apnea | remedē® System
    https://remede.zoll.com/remede-system/
    If restless nights are disrupting your days, it may be time to consider the remed System—the first and only FDA-approved non-mask therapy designed to treat moderate to severe central sleep apnea (CSA) in adults. […] The remed System reduces the number of sleep apnea events and improves sleep quality, as well as improves daytime sleepiness and quality of life as assessed by patients. […] The remed System is approved for adult patients with moderate to severe central sleep apnea.
  • #27
    https://link.springer.com/article/10.1007/s11325-021-02335-x
    Transvenous phrenic nerve stimulation (TPNS) offers an alternative, although its impact on previously PAP-treated patients with CSA has not been examined. […] TPNS is a viable therapy across a broad spectrum of CSA patients. […] TPNS could therefore overcome the physiologic, clinical, and lifestyle challenges of PAP therapy. […] TPNS improves CSA and its immediate nocturnal and daytime sequelae in patients with and without prior PAP therapy. […] TPNS offers CSA patients a well-tolerated, efficacious therapeutic approach with potential for substantial clinical benefit over PAP-based therapy. […] TPNS can be considered a viable therapeutic option for patients with moderate to severe CSA who are either PAP-nave or in whom PAP is poorly tolerated, ineffective, or contraindicated.
  • #28 ECU Health offers innovative treatment option for patients with Central Sleep Apnea – ECU Health
    https://www.ecuhealth.org/ecu-health-offers-innovative-treatment-option-for-patients-with-central-sleep-apnea/
    The remed System is an innovative, FDA-approved medical implant indicated for adult patients with Central Sleep Apnea (CSA) and its now an available treatment option for certain ECU Health patients. […] The remed System provides a significant advance in the treatment of CSA when other interventions are not effective. […] Theres a very low risk with this treatment, and phrenic nerve stimulation is a contemporary option for patients with CSA who havent responded well to other therapies, he said. […] This provides care to a significant population and will provide an overall improvement in patients quality of life while resulting in fewer hospitalizations achievements that align with ECU Healths mission and values.
  • #29 A new pill to treat sleep apnea | Perio Implant Advisory
    https://www.perioimplantadvisory.com/clinical-tips/article/55056213/a-new-pill-to-treat-sleep-apnea
    A new pill called AD109, currently in phase III clinical trials, has been created to relieve the symptoms of sleep apnea and prevent the upper airway from closing. […] These drugs can really work as they help with upper airway dilation, and they need this drug combination because muscles are different in REM sleep versus non-REM sleep. […] This study does, however, offer promise in advancing OSA treatment therapeutics, especially for the treatment of patients who suffer from mild to moderate forms of sleep apnea.
  • #30
    https://wesper.co/blogs/wesper-journal/treatment-options-for-central-sleep-apnea
    Adopting lifestyle changes like weight management, quitting smoking, reducing alcohol intake, and incorporating regular exercise can greatly enhance CSA management. These changes improve overall respiratory health and sleep quality, complementing medical treatments. […] A multidisciplinary approach ensures that various healthcare professionals, such as respiratory therapists, cardiologists, and educators, collaborate to provide comprehensive care addressing both symptoms and underlying causes of CSA. This tailored care leads to improved treatment outcomes and quality of life for patients.
  • #31 Identification and Treatment of Central Sleep Apnoea: Beyond SERVE-HF | CFR Journal
    https://www.cfrjournal.com/articles/identification-and-treatment-central-sleep-apnoea-beyond-serve-hf?language_content_entity=en
    Central sleep apnoea (CSA) occurs in a large proportion of HF patients. CSA has clear detrimental effects, resulting in intermittent hypoxia and sympathetic activation, and is associated with significant morbidity and mortality. Treatment options are limited following the results of a recent trial in which adaptive servo-ventilation resulted in an increase in cardiovascular mortality. A new neurostimulation therapy, phrenic nerve stimulation, has offered a new physiological approach to the treatment of CSA. This therapy has resulted in improvements in the severity of disease and quality of life. […] Central sleep apnoea (CSA) occurs in approximately one-third of patients with HF and is associated with a significant increase in morbidity and mortality compared to HF patients without CSA. CSA results in intermittent hypoxia and activation of the reninangiotensin system, which contributes to worsening HF.
  • #32 Central sleep apnea | MedLink Neurology
    https://www.medlink.com/articles/central-sleep-apnea
    Prevention is possible in some cases by avoiding factors that precipitate or exacerbate central sleep apnea. […] Optimal treatment of heart failure, avoiding the use of respiratory depressants, such as opiates, and treatments to avoid hypercapnic states and sleep fragmentations could potentially alleviate the severity and occurrence of central sleep apnea. […] Early interventions to treat the underlying cause of central sleep apnea may prevent a vicious cycle of respiratory disturbances that lead to worsening acidosis and sleep fragmentation.
  • #33 Identification and Treatment of Central Sleep Apnoea: Beyond SERVE-HF | CFR Journal
    https://www.cfrjournal.com/articles/identification-and-treatment-central-sleep-apnoea-beyond-serve-hf?language_content_entity=en
    Importantly, the FDA approved the use of phrenic nerve stimulation in moderate to severe CSA in adult patients, without regard for the presence of HF or ejection fraction, making phrenic nerve stimulation the only approved treatment in the US for CSA in HF patients with ejection fraction 45 %. […] CSA clearly has chronic and detrimental effects on HF patients. While symptoms may be difficult to identify, there is clear benefit in QOL with treatment of CSA using phrenic nerve stimulation, but this has not been observed with other therapies.
  • #34 Central Sleep Apnea: Causes & Treatments – Sleep Foundation | Lung & Sleep Wellness Center
    https://lungsleepwellness.com/central-sleep-apnea-causes-treatments-sleep-foundation/
    Central sleep apnea (CSA) is a disorder that affects breathing during sleep. It is distinct from obstructive sleep apnea (OSA), which is much more common and well-known. […] The key to treating central sleep apnea is addressing any underlying health issues that are causing the condition. The type of treatment for central sleep apnea depends on the category and subtype of central sleep apnea. […] For many patients with central sleep apnea, the use of CPAP or BiPAP machines can decrease cessations in respiration. […] In 2017, the Food and Drug Administration (FDA) approved an implantable device that stimulates breathing-related muscles as a treatment for CSA. This treatment has shown promise in improving breathing and sleep quality in some research studies.
  • #35 Controlling My Central Sleep Apnea – MyApnea
    https://myapnea.org/forum/controlling-my-central-sleep-apnea
    I have been a CPAP user since last fall following my diagnosis of severe SA with a primary Central Sleep Apnea component. […] A CPAP is not designed to and cannot treat Central Apnea. „Treatment” of Central Apnea using CPAP and BiLevel without Backup is by avoiding Central Apnea. […] If you have pure central sleep apnea then a CPAP is probably not going to work. An ASV is more appropriate. […] If you can’t stay under 5 and it is almost all CA then an ASV may be worth looking into. […] The disturbing part of central apnea is that if it is not drug related, it most often indicates cardiovascular issues. And they should always be investigated and treated on their own merit. […] Over the months I reduced the maximum pressure and increased the minimum pressure until I only had about 1 cm difference.